Matches in Nanopublications for { ?s ?p "[BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP272429.RAd2qNl_b_iYZsuqyi3dVt1Lwg0mTYnMiAn3gR6V--HeU130_assertion description "[BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272429.RAd2qNl_b_iYZsuqyi3dVt1Lwg0mTYnMiAn3gR6V--HeU130_provenance.
- NP1134236.RAAIw4fvRl5_xyEmO5nk2RUJ2EaPY6tjfIfEyAjtjKgrk130_assertion description "[BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134236.RAAIw4fvRl5_xyEmO5nk2RUJ2EaPY6tjfIfEyAjtjKgrk130_provenance.
- NP1134239.RAuW_mF7dy0-rFjKXXv46X9DKCU7x-ykz5mCIfkcOu3Bs130_assertion description "[BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134239.RAuW_mF7dy0-rFjKXXv46X9DKCU7x-ykz5mCIfkcOu3Bs130_provenance.
- NP272598.RAL34yet2H0OwJC19VfNuB_Hgev9oBMlqhhN_O-xGGcv0130_assertion description "[BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272598.RAL34yet2H0OwJC19VfNuB_Hgev9oBMlqhhN_O-xGGcv0130_provenance.